. | Case 1 . | Case 2 . | Control15,–17 . |
---|---|---|---|
Serum | |||
CRP, mg/dL | 0.23 | 0.78 | <1.0 |
RSV (NT), fold | 16 | 16 | <2 |
RSV (CF), fold | <2 | <2 | <2 |
IL-6, pg/mL | 6370 | 4120 | <19.9 |
IL-8, pg/mL | 154 | 140 | <15.0 |
IL-10, pg/mL | <2 | <2 | <14.2 |
INF-γ, IU/mL | 0.2 | 0.2 | <42.9 |
Cerebrospinal fluid | |||
RSV (NT), fold | — | <1 | — |
RSV (CF), fold | — | <1 | — |
IL-6, pg/mL | — | 427 | <9.7 |
IL-8, pg/mL | — | 412 | <30.0 |
IL-10, pg/mL | — | <2 | <6.1 |
Lung tissue | |||
RT-PCR | RSV-A | RSV-B | — |
. | Case 1 . | Case 2 . | Control15,–17 . |
---|---|---|---|
Serum | |||
CRP, mg/dL | 0.23 | 0.78 | <1.0 |
RSV (NT), fold | 16 | 16 | <2 |
RSV (CF), fold | <2 | <2 | <2 |
IL-6, pg/mL | 6370 | 4120 | <19.9 |
IL-8, pg/mL | 154 | 140 | <15.0 |
IL-10, pg/mL | <2 | <2 | <14.2 |
INF-γ, IU/mL | 0.2 | 0.2 | <42.9 |
Cerebrospinal fluid | |||
RSV (NT), fold | — | <1 | — |
RSV (CF), fold | — | <1 | — |
IL-6, pg/mL | — | 427 | <9.7 |
IL-8, pg/mL | — | 412 | <30.0 |
IL-10, pg/mL | — | <2 | <6.1 |
Lung tissue | |||
RT-PCR | RSV-A | RSV-B | — |
RT-PCR was performed with a Cycleave PCR respiratory infectious virus detection kit (Takara Bio, Kusatsu, Japan). CF, complement fixation test; NT, neutralization test; —, data not available.